SCHEMBL31577289

SCHEMBL31577289

CNc1nc(Nc2ncccc2-c2ccc(CN3CCOCC3)nc2)c(C(=O)O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.36
▸ CCNC P24863 2/20 0.35
▸ CDK8 P49336 2/20 0.35
▸ MAPK14 Q16539 2/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ AOC3 Q16853 1/20 0.34
▸ SYK P43405 2/20 0.32
▸ ELANE P08246 1/20 0.32
▸ AXL P30530 1/20 0.32
▸ TYRO3 Q06418 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ FGFR3 P22607 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ MITF O75030 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ CASP9 P55211 1/20 0.32
▸ CASP6 P55212 1/20 0.32
▸ CASP8 Q14790 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206281 0.88 HRH3 (0.37) HRH3CCNCCDK8SYKFGFR3
SCHEMBL29173651 0.88 HRH3 (0.37) HRH3CCNCCDK8SYKFGFR3
SCHEMBL24943841 0.82 SYK (0.38) HRH3CCNCCDK8SYKAXL
SCHEMBL29173450 0.81 FGFR3 (0.39) HRH3CCNCCDK8MAPK14SYK
SCHEMBL30206332 0.81 FGFR3 (0.39) HRH3CCNCCDK8MAPK14SYK
Formic Acid SCHEMBL30205745 0.80 SYK (0.36) HRH3CCNCCDK8SYKAXL
Formic Acid SCHEMBL29173273 0.80 SYK (0.36) HRH3CCNCCDK8SYKAXL
SCHEMBL30206132 0.79 LRRK2 (0.36) CCNCCDK8KCNH2SYKEGFR
SCHEMBL29173704 0.79 LRRK2 (0.36) CCNCCDK8KCNH2SYKEGFR
SCHEMBL29173539 0.78 SYK (0.41) SYKSRCABL1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
Send feedback